GlassScriptPhysician profile
Joy Maulik
NPI 1508226713
$47,165.56
in general payments reported to CMS, 2019-2025
29 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $1,114 · 2023: $7,959 · 2024: $12K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Travel and Lodging: $10K · Food and Beverage: $6,887 · Consulting Fee: $6,828 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,401.50 |
| Travel and Lodging | $10,417.38 |
| Food and Beverage | $6,886.95 |
| Consulting Fee | $6,828.00 |
| Education | $169.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $34,089.39 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $6,796.01 | 2021-2025 | Provenge |
| Janssen Biotech, INC. | $1,825.19 | 2021-2025 | Erleada, Akeega, Carvykti |
| Janssen Pharmaceuticals, INC | $1,160.00 | 2025 | |
| Abbvie INC. | $486.07 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $412.16 | 2022-2025 | Pylarify |
| Astellas Pharma US INC | $332.55 | 2021-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $322.62 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $301.72 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Teleflex LLC | $273.94 | 2022-2025 | Urolift, Barrigel |
| Immunitybio, INC. | $135.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $104.20 | 2023-2025 | |
| Medtronic, INC. | $102.74 | 2023-2024 | Interstim |
| Boston Scientific Corporation | $102.40 | 2023-2025 | Ams 800 Artificial Urinary Sphincter, Ams 700, Upsylon |
| Sumitomo Pharma America, INC. | $95.37 | 2023-2025 | Orgovyx, Gemtesa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $91.36 | 2023 | Itind System |
| Endo USA, INC. | $88.92 | 2024-2025 | Xiaflex, Aveed |
| Tempus Ai, INC | $86.54 | 2024-2025 | Xt Cdx |
| Amgen INC. | $65.13 | 2021-2022 | |
| Accord Healthcare, INC. | $48.60 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $42.07 | 2022-2025 | Prolaris |
| 180 Medical, INC. | $39.53 | 2021 | |
| Foundation Medicine, INC. | $33.64 | 2021-2023 | Foundationone Cdx |
| Tolmar, INC. | $28.98 | 2023 | |
| Urogen Pharma, INC. | $25.16 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $23.08 | 2021 | |
| Urovant Sciences INC | $20.61 | 2021 | |
| Laborie Medical Technologies Corp. | $17.51 | 2025 | Endosheath Technology |
| Endo Pharmaceuticals INC. | $14.90 | 2024 | Xiaflex, Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Maulik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.